Biology:MYBL2

From HandWiki
Revision as of 01:06, 12 February 2024 by SpringEdit (talk | contribs) (add)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Short description: Protein-coding gene in the species Homo sapiens


A representation of the 3D structure of the protein myoglobin showing turquoise α-helices.
Generic protein structure example

Myb-related protein B is a protein that in humans is encoded by the MYBL2 gene.[1]

Function

The protein encoded by this gene, a member of the MYB family of transcription factor genes, is a nuclear protein involved in cell cycle progression. The encoded protein is phosphorylated by cyclin A/cyclin-dependent kinase 2 during the S-phase of the cell cycle and possesses both activator and repressor activities. It has been shown to activate the cell division cycle 2, cyclin D1, and insulin-like growth factor-binding protein 5 genes. Transcript variants may exist for this gene, but their full-length natures have not been determined.[2] MYBL2 is deregulated in various cancer types and can contribute to cancer progression.[3][4]

Interactions

MYBL2 has been shown to interact with:

References

  1. "Mybl2 (Bmyb) maps to mouse chromosome 2 and human chromosome 20q 13.1". Genomics 35 (3): 610–2. August 1996. doi:10.1006/geno.1996.0408. PMID 8812502. https://zenodo.org/record/1229699. 
  2. "Entrez Gene: MYBL2 v-myb myeloblastosis viral oncogene homolog (avian)-like 2". https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=4605. 
  3. "MYBL2 (B-Myb): a central regulator of cell proliferation, cell survival and differentiation involved in tumorigenesis". Cell Death & Disease 8 (6): e2895. June 2017. doi:10.1038/cddis.2017.244. PMID 28640249. 
  4. "Cooperation of cancer drivers with regulatory germline variants shapes clinical outcomes". Nature Communications 10 (1): 4128. September 2019. doi:10.1038/s41467-019-12071-2. PMID 31511524. Bibcode2019NatCo..10.4128M. 
  5. "Physical interaction between CDK9 and B-Myb results in suppression of B-Myb gene autoregulation". Oncogene 19 (3): 373–9. January 2000. doi:10.1038/sj.onc.1203305. PMID 10656684. 
  6. "Inhibition of cyclin A/Cdk2 phosphorylation impairs B-Myb transactivation function without affecting interactions with DNA or the CBP coactivator". Oncogene 20 (26): 3376–86. June 2001. doi:10.1038/sj.onc.1204439. PMID 11423988. 
  7. "Cyclin A1 directly interacts with B-myb and cyclin A1/cdk2 phosphorylate B-myb at functionally important serine and threonine residues: tissue-specific regulation of B-myb function". Blood 97 (7): 2091–7. April 2001. doi:10.1182/blood.V97.7.2091. PMID 11264176. 
  8. 8.0 8.1 "The cell cycle-regulated B-Myb transcription factor overcomes cyclin-dependent kinase inhibitory activity of p57(KIP2) by interacting with its cyclin-binding domain". The Journal of Biological Chemistry 278 (45): 44255–64. November 2003. doi:10.1074/jbc.M308953200. PMID 12947099. 
  9. "Effects of B-Myb on gene transcription: phosphorylation-dependent activity and acetylation by p300". The Journal of Biological Chemistry 277 (6): 4088–97. February 2002. doi:10.1074/jbc.M105112200. PMID 11733503. 
  10. "Poly(ADP-ribose) polymerase is a B-MYB coactivator". The Journal of Biological Chemistry 275 (14): 10692–6. April 2000. doi:10.1074/jbc.275.14.10692. PMID 10744766. 
  11. "B-Myb overcomes a p107-mediated cell proliferation block by interacting with an N-terminal domain of p107". Oncogene 21 (52): 7923–32. November 2002. doi:10.1038/sj.onc.1206001. PMID 12439743. 

Further reading

External links

This article incorporates text from the United States National Library of Medicine, which is in the public domain.